Mycobacterium Infections
Showing 26 - 50 of 7,571
Major Mycobacterium Species in Pulmonary Infection Based on
Recruiting
- Mycobacterium Pulmonary Infection
- Detection method
-
Shanghai, ChinaHaiqing Chu
Sep 29, 2021
Lung Infection, Mycobacterium Avium Complex Trial in Amiens, Marseille (Clarithromycin 1000 MG, Azithromycin 250 mg, Rifampicin)
Recruiting
- Lung Infection
- Mycobacterium Avium Complex
- Clarithromycin 1000 MG
- +3 more
-
Amiens, Picardie, France
- +1 more
Aug 23, 2021
Expectorated and Induced Sputum and Pharyngeal Swabs for
Completed
- Myobacterium Infections, Nontuberculous
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,
Recruiting
- Mycobacterium Avium Complex
- Nontuberculous Mycobacterium Infection
- Azithromycin
- +2 more
-
Loma Linda, California
- +26 more
Jan 18, 2023
Human Immunodeficiency Virus Trial in South Africa (M72/AS01E Mycobacterium tuberculosis vaccine, Placebo)
Active, not recruiting
- Human Immunodeficiency Virus
- M72/AS01E Mycobacterium tuberculosis vaccine
- Placebo
-
Johannesburg, Gauteng, South Africa
- +5 more
Feb 26, 2022
Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) Trial in United States (Molgramostim nebulizer solution, PARI
Terminated
- Mycobacterium Infections, Nontuberculous
- Cystic Fibrosis (CF)
- Molgramostim nebulizer solution
- PARI eFlow nebulizer system
-
Denver, Colorado
- +4 more
Oct 10, 2021
s for Non-tuberculous Mycobacterial Infections in Cancer
Recruiting
- Mycobacterium
- +2 more
-
Amiens, Picardie, FranceCHU Amiens Picardie
Aug 31, 2021
Pulmonary Mycobacterium Avium Complex Infection, Bronchiectasis, Lung Diseases Trial in United States (RHB-204, Placebo)
Recruiting
- Pulmonary Mycobacterium Avium Complex Infection
- +2 more
- RHB-204
- Placebo
-
Glendale, California
- +24 more
Jan 23, 2023
Cystic Fibrosis, Bronchiectasis Adult, Non-Tuberculous Mycobacteria Trial in Baltimore (BCG TICE Vaccine)
Recruiting
- Cystic Fibrosis
- +2 more
- BCG TICE Vaccine
-
Baltimore, MarylandJohns Hopkins University
Jan 26, 2022
Mycobacterium Avium Complex, Non-tuberculous Mycobacterium Pulmonary Disease Trial in United States (SPR720, Placebo, Open-label
Terminated
- Mycobacterium Avium Complex
- Non-tuberculous Mycobacterium Pulmonary Disease
- SPR720
- +2 more
-
Altamonte Springs, Florida
- +8 more
Feb 3, 2022
Mycobacterium Tuberculosis Infection Trial in Worldwide (VPM1002, BCG SII)
Active, not recruiting
- Mycobacterium Tuberculosis Infection
- VPM1002
- BCG SII
-
Lambaréné, Gabon
- +11 more
Dec 19, 2022
Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections Respiratory Trial in Groningen (500mg BTZ-043 containing 3.7 MBq of
Completed
- Tuberculosis
- +4 more
- 500mg BTZ-043 containing 3.7 MBq of [14C]BTZ-043
-
Groningen, NetherlandsPRA Health Sciences (PRA) - Early Development Services (EDS)
Oct 19, 2021
Tuberculosis Trial in South Africa (BCG vaccine SSI, Placebo)
Active, not recruiting
- Tuberculosis
- BCG vaccine SSI
- Placebo
-
Klipfontein, Cape Town, South Africa
- +4 more
Aug 10, 2021
Nontuberculous Mycobacterium Infection Trial in Portland, Charleston (gNO)
Completed
- Nontuberculous Mycobacterium Infection
-
Portland, Oregon
- +1 more
May 17, 2021
Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)
Recruiting
- Pulmonary Disease Due to Mycobacteria (Diagnosis)
- Amikacin
- +13 more
-
South Brisbane, Queensland, Australia
- +36 more
Sep 12, 2022
Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Ciprofloxacin HCl, Ethambutol HCl, Amikacin sulfate)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Ciprofloxacin hydrochloride
- +5 more
-
Torrance, California
- +15 more
Oct 26, 2021
Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of
Completed
- Mycobacterium Avium-intracellulare Infection
- +2 more
-
San Francisco, California
- +14 more
Oct 27, 2021
Mycobacterium Infections, Nontuberculous Trial in Australia, United Kingdom (Inhaled molgramostim)
Completed
- Mycobacterium Infections, Nontuberculous
- Inhaled molgramostim
-
Concord, New South Wales, Australia
- +4 more
Mar 23, 2021
Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Ethambutol HCl, Clarithromycin, Clofazimine)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Ethambutol hydrochloride
- +3 more
-
San Francisco, California
- +15 more
Oct 28, 2021
Filarial Infection on Immune Responses in Latent Tuberculosis
Completed
- Mycobacterium Infections
- +3 more
-
Bethesda, Maryland
- +1 more
Apr 19, 2021
Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Trial in Japan (Bedaquiline, Clarithromycin, Ethambutol)
Recruiting
- Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
- Bedaquiline
- +4 more
-
Aichi, Japan
- +42 more
Jan 17, 2023
Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Azithromycin)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
-
San Francisco, California
- +18 more
Oct 27, 2021
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Active, not recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +110 more
Jan 23, 2023